Zhang Dan, Ren Yikun, He Yuanmeng, Chang Rong, Guo Shen, Ma Shanshan, Guan Fangxia, Yao Minghao
School of Life Science, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, PR China.
Mater Today Bio. 2022 May 10;15:100278. doi: 10.1016/j.mtbio.2022.100278. eCollection 2022 Jun.
The efficacy of neural repair and regeneration strategies for traumatic brain injury (TBI) treatment is greatly hampered by the harsh brain lesion microenvironment including oxidative stress and hyper-inflammatory response. Functionalized hydrogel with the capability of oxidative stress suppression and neuroinflammation inhibition will greatly contribute to the repairment of TBI. Herein, antioxidant gallic acid-grafted hyaluronic acid (HGA) was combined with hyaluronic acid-tyramine (HT) polymer to develop an injectable hydrogel by dual-enzymatically crosslinking method. The resulting HT/HGA hydrogel is biocompatible and possesses effective scavenging activity against DPPH and hydroxyl radicals. Meanwhile, this hydrogel improved cell viability and reduced intracellular reactive oxygen species (ROS) production under HO insult. The study showed that injection of HT/HGA hydrogel significantly reduced malondialdehyde (MDA) production and increased glutathione (GSH) expression in lesion area after treatment for 3 or 21 days, which might be associated with the activation of Nrf2/HO-1 pathway. Furthermore, this hydrogel promoted the microglia polarization to M2 (Arg1) phenotype, it also decreased the level of proinflammatory factors including TNF-α and IL-6 and increased anti-inflammatory factor expression of IL-4. Finally, blood-brain barrier (BBB) was protected, neurogenesis in hippocampus was promoted, and the motor, learning and memory ability was enhanced. Therefore, this injectable, biocompatible, and antioxidant hydrogel exhibits a huge potential for treating TBI and allows us to recognize the great value of this novel biomaterial for remodeling brain structure and function.
创伤性脑损伤(TBI)治疗中神经修复和再生策略的疗效受到包括氧化应激和过度炎症反应在内的恶劣脑损伤微环境的极大阻碍。具有氧化应激抑制和神经炎症抑制能力的功能化水凝胶将极大地有助于TBI的修复。在此,将抗氧化剂没食子酸接枝的透明质酸(HGA)与透明质酸-酪胺(HT)聚合物相结合,通过双酶交联法制备了一种可注射水凝胶。所得的HT/HGA水凝胶具有生物相容性,并对DPPH和羟基自由基具有有效的清除活性。同时,这种水凝胶提高了细胞活力,并在过氧化氢损伤下减少了细胞内活性氧(ROS)的产生。研究表明,注射HT/HGA水凝胶在治疗3天或21天后,显著降低了损伤区域丙二醛(MDA)的产生,并增加了谷胱甘肽(GSH)的表达,这可能与Nrf2/HO-1通路的激活有关。此外,这种水凝胶促进小胶质细胞向M2(Arg1)表型极化,还降低了包括肿瘤坏死因子-α和白细胞介素-6在内的促炎因子水平,并增加了白细胞介素-4的抗炎因子表达。最后,血脑屏障(BBB)得到保护,海马区神经发生得到促进,运动、学习和记忆能力得到增强。因此,这种可注射、生物相容且具有抗氧化作用的水凝胶在治疗TBI方面具有巨大潜力,使我们认识到这种新型生物材料在重塑脑结构和功能方面的巨大价值。